4//SEC Filing
Redfield Robert 4
Accession 0000929638-24-001366
CIK 0001130598other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:07 PM ET
Size
4.8 KB
Accession
0000929638-24-001366
Insider Transaction Report
Form 4
Redfield Robert
Chief Medical Officer
Transactions
- Award
Common Stock
2024-04-01+97,500→ 97,500 total
Footnotes (1)
- [F1]Represents an award of restricted stock units that will vest in four equal annual installments beginning April 1, 2025. Each restricted stock unit will convert into common stock of Traws Pharma, Inc. (f/k/a Onconova Therapeutics, Inc.), par value $0.01 per share, on a one-for-one basis.
Documents
Issuer
Traws Pharma, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0002018274
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 8:07 PM ET
- Size
- 4.8 KB